Health Care/Hospital
Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody (W0180) targeting the VISTA checkpoint in patients with solid tumors
TOULOUSE, France, Nov. 9, 2020 /PRNewswire/ -- Pierre Fabre announced today the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its investigational product W0180, an innovative monoclonal antibody targeting VISTA, developed by Pierre ...
2020-11-09 20:57
1860
FTLife Launches "HealthCare 168 Plus" Critical Illness Protector
HONG KONG, Nov. 9, 2020 /PRNewswire/ -- FTLife Insurance Company Limited ("FTLife") today announced the launch of "HealthCare 168 Plus" Critical Illness Protector ("HealthCare 168 Plus" or "the Plan"), aggregated with two first-in-market[1] features including additional monthly financial support ...
2020-11-09 20:08
2530
OrbusNeich® Medical and P+F Products & Features® announce new partnership
Introducing a new portfolio of heart valve products aiming to restore health and extend life HONG KONG, Nov. 9, 2020 /PRNewswire/ -- OrbusNeich and P+F today announced they have entered into an agreement for the exclusive distribution and manufacturing of a range of innovative minimally invasive...
2020-11-09 19:00
2532
The world's largest RCT investigating use of MagicTouch PTA Sirolimus Coated balloon for peripheral artery disease kicks off to a flying start
ZÜRICH, Nov. 9, 2020 /PRNewswire/ -- Concept Medical Inc.,
2020-11-09 18:55
2052
Covid-19 Vaccination Plan: Badan POM Set to Ensure and Safeguard the safety, efficacy, and quality of Covid-19 vaccine
* Prudent approach and usability are among the top priorities * Efforts are underway to provide the best efficacy for public at large JAKARTA, Indonesia, Nov. 9, 2020 /PRNewswire/ -- In a bid to support the government's plan to develop Covid-19 vaccine inIndonesia, the National Drug and Food ...
2020-11-09 17:25
2136
SynAct Pharma Announces Positive Interim Phase 2 Data of AP1189 in Rheumatoid Arthritis
* The Data Safety Monitoring Board (DSMB) finds no safety concerns in the 50 mg and 100 mg dose cohorts * Signs of efficacy against rheumatoid arthritis was observed. Thus, the number of patients changing from the severe to the moderate Clinical Disease Activity Index (CDAI) score was higher ...
2020-11-09 15:22
1043
New Research Study Supports Clinical Utility of Circulating Tumor Cell Count for Metastatic Breast Cancer
First randomized clinical trial demonstrating that CTC count may help personalize treatment choices BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Nov. 9, 2020 /PRNewswire/ -- Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, today announced the publication of a research study pr...
2020-11-09 15:00
1032
For 2020, The World Innovation Summit for Health (WISH) Delivers Leading Speakers and Compelling Discussions via an Immersive Virtual Platform
DOHA, Qatar, Nov. 9, 2020 /PRNewswire/ -- The World Innovation Summit for Health (WISH) returns on15 November, 2020, offering an impressive range of speakers, networking opportunities, discussions and presentations that explore global health challenges, and – all presented through a purpose-built...
2020-11-09 09:00
2225
Ascentage Pharma to Release Updated Clinical Results of HQP1351 (Olverembatinib) in Drug-Resistant Chronic Myeloid Leukemia in an Oral Presentation at the American Society of Hematology Annual Meeting
SUZHOU, China and ROCKVILLE, Md., Nov. 9, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the results from two piv...
2020-11-09 08:04
1715
Togetherall secures $10 million investment from FPE Capital
LONDON, Nov. 9, 2020 /PRNewswire/ -- Leading online mental health platform,
Togetherall
2020-11-09 08:01
2566
Large Study Shows That A Simple Blood Test Can Accurately Differentiate Between Benign and Malignant Lesions
LONDON, Nov. 9, 2020 /PRNewswire/ -- A large, landmark study published in the American Cancer Society's prestigious journal 'Cancer Cytopathology' shows that a simple non-invasive blood test (liquid biopsy) can accurately differentiate between non-cancerous tumors versus cancerous growths. These...
2020-11-09 07:00
1856
Merck and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the 'Facility of the Future' a Reality
* Companies to co-develop a first-of-its-kind, single-use flow-through polishing system for GMP operation * Merck's continuous processing expertise to accelerate Transcenta's development, implementation of continuous bioprocessing platform * Collaboration expected to accelerate affordable ac...
2020-11-08 17:14
3091
Merck to Collaborate with Donghao Lansheng to Pilot New Import Policy in China
* Merck is first international company to pilot the new custom clearance
process SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 6, Merck
2020-11-08 17:08
2457
ZEISS Attends the CIIE for the Third Consecutive Time to Showcase Innovative Optical Technologies
SHANGHAI, Nov. 7, 2020 /PRNewswire/ -- The opening ceremony of the third China International Import Expo (CIIE) took place at the National Convention and Exhibition Center (Shanghai) on November 4, demonstrating China's open and inclusive attitude to the world. This is the third consecutive time ...
2020-11-07 20:45
2948
Jeju Forum opens to discuss multilateral cooperation on pandemic, security
JEJU, South Korea, Nov. 6, 2020 /PRNewswire/ -- Organized by Jeju Peace Institute, an annual international peace forum opened on the southern resort island of Jeju on Thursday, with a focus on ways to shore up multilateral cooperation in tackling the coronavirus pandemic and promoting regional s...
2020-11-06 17:53
2828
Johnson & Johnson Innovation Announces Three Strategic Collaborations with a Focus on Advancing Healthcare Solutions in China
SHANGHAI, Nov. 6, 2020 /PRNewswire/ -- Johnson & Johnson Innovation, division of Johnson & Johnson (China) Investment Limited, announced today three new collaborations with strategic partners inChina at the third China International Import Expo (CIIE) inShanghai. These latest collaborations, faci...
2020-11-06 16:52
5644
Prebona proves unique, long-term effect against COVID-19/SARS CoV-2
STOCKHOLM, Nov. 6, 2020 /PRNewswire/ -- Independent test-institutes have confirmed that Prebona Disinfect is extremely effective against the coronavirus - SARS CoV-2, COVID-19. The tests, conducted on textiles, shows that before and even after 10 machine washes, Prebona Disinfect still eliminates...
2020-11-06 16:15
1719
Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to intensive behavioural therapy
BAGSVÆRD, Denmark, Nov. 6, 2020 /PRNewswire/ -- Results of a phase 3a trial showed that investigational drug semaglutide 2.4 mg once-weekly subcutaneous as an adjunct to intensive behavioural therapy (IBT) demonstrated significantly more body weight loss compared to placebo plus IBT.[i] The STEP ...
2020-11-06 01:50
2329
Bactiguard maintains clear growth strategy and updates financial targets
STOCKHOLM, Nov. 5, 2020 /PRNewswire/ -- Bactiguard presents updated financial targets for 2025 in connection with the company's financial report for the third quarter of 2020. Bactiguard's growth strategy for the coming five-year period up to 2025 is based on a continued roll-out of Bactiguard's...
2020-11-05 17:52
6360
MEBO International Attended CIIE for the Third Time
SHANGHAI, Nov. 5, 2020 /PRNewswire/ -- On November 5, 2020, the third CIIE was grandly opened inShanghai. With the theme of "Regenerative World, Healthy Future," MEBO International attended the event again. This year marks the third CIIE and MEBO International has been in the event for three cons...
2020-11-05 17:44
2971
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2931
